Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity
The purpose of the study is to conduct a cross-sectional study to examine asthma prevalence and morbidity in a predominately minority, low-income population in rural Arkansas.
|Study Design:||Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
|Official Title:||Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity|
- The findings suggest that asthma diagnosis and active symptoms are prevalent among this predominately minority and low-income rural population in the Arkansas region of the Mississippi Delta. [ Time Frame: One year ] [ Designated as safety issue: No ]
- High rates of inadequately controlled asthma are evidenced by activity limitation, medication use and increased healthcare utilization. [ Time Frame: One year ] [ Designated as safety issue: No ]
|Study Start Date:||August 2005|
|Study Completion Date:||August 2008|
|Primary Completion Date:||May 2006 (Final data collection date for primary outcome measure)|
Children at risk for asthma were identified using a cross-sectional asthma screening survey.
Asthma is the leading chronic disease of childhood in the United States and an important public health concern in Arkansas. Arkansas, a predominately rural state, has one of the leading mortality rates in the nation for African Americans. The specific aims of the study will examine asthma prevalence in children age 4-17 years old in public schools in Eudora and Marvell Arkansas. The study will also examine asthma morbidity among identified asthmatics by characterizing activity limitation, days missed from school, daytime and nocturnal symptoms, healthcare utilization and medication use. The specific aims of the current study will provide novel data on an understudied population of asthmatics and will test our working hypotheses that pediatric asthma prevalence in the Delta region of Arkansas is higher than national estimates; and asthma diagnosis is related to significant morbidity among rural asthmatics.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00589719
|United States, Arkansas|
|Arkansas Children's Hospital Research Institute|
|Little Rock, Arkansas, United States, 72202|
|Principal Investigator:||Tamara T. Perry, M.D.||University of Arkansas|